LCP

Lamond Capital Partners Portfolio holdings

AUM $14.3M
1-Year Est. Return 19.1%
This Quarter Est. Return
1 Year Est. Return
-19.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$66.9M
AUM Growth
-$10.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
13
New
Increased
Reduced
Closed

Top Buys

1
+$18.3M
2
+$17.8M
3
+$17.3M
4
RXDX
Ignyta, Inc.
RXDX
+$626K
5
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$460K

Top Sells

1
+$17.3M
2
+$15.6M
3
+$11M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.5M
5
CY
Cypress Semiconductor
CY
+$9.37M

Sector Composition

1 Healthcare 72.24%
2 Technology 27.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
1
Oracle
ORCL
$695B
$18.3M 27.3%
+500,000
ABBV icon
2
AbbVie
ABBV
$387B
$17.8M 26.56%
+300,000
PBYI icon
3
Puma Biotechnology
PBYI
$247M
$17.3M 25.87%
+220,780
AMGN icon
4
Amgen
AMGN
$170B
$12.2M 18.2%
75,000
-25,000
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
$626K 0.94%
+46,721
ZLTQ
6
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$460K 0.69%
+16,119
IMMU
7
DELISTED
Immunomedics Inc
IMMU
$307K 0.46%
+100,000
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$9.96B
– –
-100,000
OCUL icon
9
Ocular Therapeutix
OCUL
$2.26B
– –
-1,233,285
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-100,000
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-120,000
KITE
12
DELISTED
Kite Pharma, Inc.
KITE
– –
0
CY
13
DELISTED
Cypress Semiconductor
CY
– –
-1,100,000